TBPHTheravance Biopharma, Inc.

TBPH Stock Price, Valuation & Chart | Theravance Biopharma, Inc.

Compare

$17.070+0.04 (+0.23%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology TBPH intrinsic value TBPH calculated fair value vs price

Overview Financials Dividends Ratios

TBPH Historical price chart

TBPH Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization884.71M

PE Ratio-160.7

EPS-0.11

Trading Volume560.19K

Today's High/Low17.08/17.02

Dividend Yield0.00

52 Week High/Low21.03/13.08

Shares Outstanding51.83M

TBPH Financial Statement

TBPH Analyst ratings

TBPH Analysis & performance metrics

TBPH Company profile

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company…

Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also include Izencitinib, a gut-selective…

TBPH Management team

Name

Position

Rick E. Winningham M.B.A.CEO

Chief Executive Officer & Director

Aine Miller Ph.D.

Senior Vice President of Development & Head of Ireland Office

Brett A. Grimaud Esq.

Senior Vice President, General Counsel & Secretary

Rhonda F. Farnum

Chief Business Officer and Senior Vice President of Commercial & Medical Affairs

Stacy L. Pryce

Senior Vice President & Chief Strategy Officer

Aziz Sawaf C.F.A.CFO

Senior Vice President & Chief Financial Officer

Stuart KnightCTO

Senior Vice President of IT&I and Chief Information Officer

Name

Position

Rick E. Winningham M.B.A.CEO

Chief Executive Officer & Director

Aine Miller Ph.D.

Senior Vice President of Development & Head of Ireland Office

Brett A. Grimaud Esq.

Senior Vice President, General Counsel & Secretary

Rhonda F. Farnum

Chief Business Officer and Senior Vice President of Commercial & Medical Affairs

Stacy L. Pryce

Senior Vice President & Chief Strategy Officer

Aziz Sawaf C.F.A.CFO

Senior Vice President & Chief Financial Officer

Stuart KnightCTO

Senior Vice President of IT&I and Chief Information Officer

Management Team

Rick E. Winningham M.B.A.CEO

Chief Executive Officer & Director

Aine Miller Ph.D.

Senior Vice President of Development & Head of Ireland Office

Brett A. Grimaud Esq.

Senior Vice President, General Counsel & Secretary

Rhonda F. Farnum

Chief Business Officer and Senior Vice President of Commercial & Medical Affairs

Stacy L. Pryce

Senior Vice President & Chief Strategy Officer

Aziz Sawaf C.F.A.CFO

Senior Vice President & Chief Financial Officer

Stuart KnightCTO

Senior Vice President of IT&I and Chief Information Officer

Management

Rick E. Winningham M.B.A.CEO

Chief Executive Officer & Director

Aine Miller Ph.D.

Senior Vice President of Development & Head of Ireland Office

Brett A. Grimaud Esq.

Senior Vice President, General Counsel & Secretary

Rhonda F. Farnum

Chief Business Officer and Senior Vice President of Commercial & Medical Affairs

Stacy L. Pryce

Senior Vice President & Chief Strategy Officer

Aziz Sawaf C.F.A.CFO

Senior Vice President & Chief Financial Officer

Stuart KnightCTO

Senior Vice President of IT&I and Chief Information Officer

Total 7 executives

TBPH Frequently asked questions

What is Theravance Biopharma, Inc. (TBPH) Stock Price?

Current stock price of Theravance Biopharma, Inc. (TBPH) stock is $17.070. The stock price is +0.23% higher in the session. The intraday range can be seen from this page. Volume of Theravance Biopharma, Inc. (TBPH) stock is 560.19K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Theravance Biopharma, Inc. (TBPH) stock price going up or down today?

The stock price of Theravance Biopharma, Inc. (TBPH) can change with earnings, company news, and overall market sentiment. Theravance Biopharma, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Theravance Biopharma, Inc. stock expensive at its current price?

Whether Theravance Biopharma, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TBPH on this page is -160.73. EPS on this page is -0.11. Compare those figures with peers and growth expectations before deciding if the current Theravance Biopharma, Inc. price is justified.

How has the stock price of Theravance Biopharma, Inc. (TBPH) performed historically?

Historical performance for Theravance Biopharma, Inc. (TBPH) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TBPH reacted to past earnings and market events.

Should I buy Theravance Biopharma, Inc. (TBPH) stock, at this price?

Buying Theravance Biopharma, Inc. (TBPH) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.